BRPI0416821A - processo para a preparação de pirazolo[1,5-a]-1,3,5-triazinas e seus intermediários - Google Patents

processo para a preparação de pirazolo[1,5-a]-1,3,5-triazinas e seus intermediários

Info

Publication number
BRPI0416821A
BRPI0416821A BRPI0416821-6A BRPI0416821A BRPI0416821A BR PI0416821 A BRPI0416821 A BR PI0416821A BR PI0416821 A BRPI0416821 A BR PI0416821A BR PI0416821 A BRPI0416821 A BR PI0416821A
Authority
BR
Brazil
Prior art keywords
preparation
intermediates
triazines
pyrazolo
crf
Prior art date
Application number
BRPI0416821-6A
Other languages
English (en)
Inventor
James P Sherbine
Shawn K Pack
Jaan A Pesti
Robert E Yule
Kenneth C Mcnulty
Original Assignee
Bristol Myers Squibb Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Pharma Co filed Critical Bristol Myers Squibb Pharma Co
Publication of BRPI0416821A publication Critical patent/BRPI0416821A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyridine Compounds (AREA)

Abstract

"PROCESSO PARA A PREPARAçãO DE PIRAZOLO¢1,5-a!-1,3,5-TRIAZINAS E SEUS INTERMEDIáRIOS". A presente invenção proporciona novos processos e intermediários para a preparação de antagonistas dos receptores de fator liberador de corticotropina (CRF) tendo a estrutura abaixo, que são úteis no tratamento de distúrbios relacionados ao CRF, tais como a ansiedade e a depressão.
BRPI0416821-6A 2003-11-25 2004-11-19 processo para a preparação de pirazolo[1,5-a]-1,3,5-triazinas e seus intermediários BRPI0416821A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US52505003P 2003-11-25 2003-11-25
US10/985,236 US7208596B2 (en) 2003-11-25 2004-11-10 Processes for the preparation of pyrazolo[1,5-a]-1,3,5-triazines and intermediates thereof
PCT/US2004/039046 WO2005051954A2 (en) 2003-11-25 2004-11-19 PROCESSES FOR THE PREPARATION OF PYRAZOLO[1,5-a]-1,3,5-TRIAZINES AND INTERMEDIATES THEREOF

Publications (1)

Publication Number Publication Date
BRPI0416821A true BRPI0416821A (pt) 2007-03-06

Family

ID=34636532

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0416821-6A BRPI0416821A (pt) 2003-11-25 2004-11-19 processo para a preparação de pirazolo[1,5-a]-1,3,5-triazinas e seus intermediários

Country Status (15)

Country Link
US (2) US7208596B2 (pt)
EP (1) EP1706408A2 (pt)
JP (1) JP2007512360A (pt)
KR (1) KR20060116208A (pt)
AR (1) AR046851A1 (pt)
AU (1) AU2004293435A1 (pt)
BR (1) BRPI0416821A (pt)
CA (1) CA2546652A1 (pt)
IL (1) IL175753A0 (pt)
MX (1) MXPA06005482A (pt)
NO (1) NO20062943L (pt)
PE (1) PE20051045A1 (pt)
RU (1) RU2006121075A (pt)
TW (1) TW200529827A (pt)
WO (1) WO2005051954A2 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7208596B2 (en) * 2003-11-25 2007-04-24 Bristol-Myers Squibb Pharma Company Processes for the preparation of pyrazolo[1,5-a]-1,3,5-triazines and intermediates thereof
GB0525068D0 (en) 2005-12-08 2006-01-18 Novartis Ag Organic compounds
US8349852B2 (en) 2009-01-13 2013-01-08 Novartis Ag Quinazolinone derivatives useful as vanilloid antagonists
EP2530078A1 (en) 2010-01-27 2012-12-05 Takeda Pharmaceutical Company Limited Thiazole derivative
JP2013518085A (ja) 2010-02-01 2013-05-20 ノバルティス アーゲー ＣＲＦ−１受容体アンタゴニストとしてのピラゾロ［５，１ｂ］オキサゾール誘導体
AR080056A1 (es) 2010-02-01 2012-03-07 Novartis Ag Derivados de ciclohexil-amida como antagonistas de los receptores de crf
JP5748777B2 (ja) 2010-02-02 2015-07-15 ノバルティス アーゲー Ｃｒｆ受容体アンタゴニストとしてのシクロヘキシルアミド誘導体
UY34094A (es) 2011-05-27 2013-01-03 Novartis Ag Derivados de la piperidina 3-espirocíclica como agonistas de receptores de la ghrelina
CA2867043A1 (en) 2012-05-03 2013-11-07 Novartis Ag L-malate salt of 2,7-diaza-spiro[4.5]dec-7-yle derivatives and crystalline forms thereof as ghrelin receptor agonists

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3910907A (en) 1973-07-09 1975-10-07 Icn Pharmaceuticals Pyrazolo(1,5-a)-1,3,5-triazines
US4824834A (en) 1986-10-31 1989-04-25 Otsuka Pharmaceutical Company, Limited Pyrazolotriazine compounds
DE3722072A1 (de) 1987-07-01 1989-01-12 Schering Ag 6,7-dihydro-pyrazolo(1,5-a)(1,3,5) triazin-2-sulfonsaeureamide, verfahren zu ihrer herstellung und ihre verwendung als mittel mit herbizider und pflanzenwuchsregulierender wirkung
JP2691317B2 (ja) 1989-08-25 1997-12-17 株式会社大塚製薬工場 ４―ヒドロキシ―８―（３―低級アルコキシ―４―フェニルスルフィニルフェニル）ピラゾロ〔１，５―ａ〕―１，３，５―トリアジン光学活性体の塩類及びその製造方法
US5484760A (en) 1990-12-31 1996-01-16 Monsanto Company Herbicide antidotes as safeners for reducing phytotoxicity resulting from synergistic interaction between herbicides and other pesticides
AU667575B2 (en) 1992-10-20 1996-03-28 Otsuka Pharmaceutical Co., Ltd. Condensed pyrazole derivatives, method of manufacturing the same, and androgen inhibitor
CN1088574A (zh) 1992-12-24 1994-06-29 中国科学院化学研究所 2,6-二甲基-4-叔丁基-3-硝基-苯乙氰的合成方法
US6124289A (en) 1996-07-24 2000-09-26 Dupont Pharmaceuticals Co. Azolo triazines and pyrimidines
US6191131B1 (en) 1997-07-23 2001-02-20 Dupont Pharmaceuticals Company Azolo triazines and pyrimidines
US6060478A (en) * 1996-07-24 2000-05-09 Dupont Pharmaceuticals Azolo triazines and pyrimidines
US6313124B1 (en) 1997-07-23 2001-11-06 Dupont Pharmaceuticals Company Tetrazine bicyclic compounds
HU229024B1 (en) 1996-07-24 2013-07-29 Bristol Myers Squibb Pharma Co Azolo-pyridimidines, pharmaceutical compositions containing the same and use thereof
JP3621706B2 (ja) 1996-08-28 2005-02-16 ファイザー・インク 置換された６，５―ヘテロ―二環式誘導体
ES2204798T3 (es) * 1998-12-21 2004-05-01 Lonza Ag Procedimiento para la preparacion de 2,5-diamino-4,6-dihalogenopirimidina.
ES2277855T3 (es) 1999-09-30 2007-08-01 Neurogen Corporation Pirazolo-(1,5-a)-1,5-pirimidinas y pirazolo-(1,5-a)-1,3,5-triazinas amino sustituidas.
JP2001302658A (ja) 2000-04-18 2001-10-31 Showa Denko Kk ３−イソクロマノン類の製造方法
NZ528207A (en) * 2001-03-13 2006-02-24 Bristol Myers Squibb Pharma Co 4-(2-butylamino)-2,7-dimethyl-8-(2-methyl-6-methoxypyrid-3-yl) pyrazolo-[1,5-A]-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands
US7208596B2 (en) * 2003-11-25 2007-04-24 Bristol-Myers Squibb Pharma Company Processes for the preparation of pyrazolo[1,5-a]-1,3,5-triazines and intermediates thereof

Also Published As

Publication number Publication date
US20070161790A1 (en) 2007-07-12
IL175753A0 (en) 2006-09-05
JP2007512360A (ja) 2007-05-17
AR046851A1 (es) 2005-12-28
WO2005051954A2 (en) 2005-06-09
CA2546652A1 (en) 2005-06-09
US7442792B2 (en) 2008-10-28
MXPA06005482A (es) 2006-08-11
PE20051045A1 (es) 2005-12-29
WO2005051954A3 (en) 2005-11-17
AU2004293435A1 (en) 2005-06-09
RU2006121075A (ru) 2008-01-10
KR20060116208A (ko) 2006-11-14
US20050143380A1 (en) 2005-06-30
EP1706408A2 (en) 2006-10-04
NO20062943L (no) 2006-08-25
US7208596B2 (en) 2007-04-24
TW200529827A (en) 2005-09-16

Similar Documents

Publication Publication Date Title
MY138535A (en) 2-phenyl-substituted imidazotriazinones as phosphodiesterase inhibitors
DE69726724D1 (de) Tetrahydropteridine und pyridylpiperazine zur behandlung von neurologischen störungen
BRPI0416821A (pt) processo para a preparação de pirazolo[1,5-a]-1,3,5-triazinas e seus intermediários
DK1869049T3 (da) Imidazopyridazinforbindelser
SG111076A1 (en) Azolo triazines and pyrimidines
NZ331874A (en) Arylamino fused pyridines and pyrimidines and their use in treating psychiatric and neurological diseases
BRPI0414541A8 (pt) compostos heterocíclicos fundidos, seu uso, método de preparação de compostos intermediários e método para estudar distúrbios mediados por serotonina
ATE160342T1 (de) 9h-indeno(1,2-b>pyrazin-3(4h)-one und 9h- indeno(1,2-b>pyrazine-2,3(1h,4h)-dione und ihre herstellung und verwendung
ES2299896T3 (es) Derivados de benzazepina como antagonistas h3 de histamina.
NO20022655D0 (no) <Beta>-2-adrenerge reseptoragonister
DE69812709D1 (de) Verfahren zur herstellung von apatitkeramik, insbesondere zur biologischen verwendung
BR0209575A (pt) Pirazinonas, piridinas e pirimidinas substituìdas como ligantes do fator liberador de corticotropina
DE69711430D1 (de) PYRROLO[3,4-d]PYRIMIDINON-DERIVATE UND IHRE VERWENDUNG ALS IMMUNOSUPPRESSOREN
AR032986A1 (es) 4-( 2-butilamino)-2,7-dimetil-8-(2-metil-6-metoxipirid-3il)pirazol- (1,5-a)-1,3,5-triazina, sus enantiomeros y sales aceptables para uso farmaceutico como ligandos del receptor del factor liberador de corticotropina
WO2004073628A3 (en) Novel compounds
CL2004000847A1 (es) Compuestos derivados de 2-alquinil o 2-alquenil-5amino-pirazolo-[4,3-e]-1,2,4-triazolo[1,5-]pirimidina; composicion farmaceutica, y uso en el tratamiento de enfermedades del sistema nervioso central o un accidente cerebrovascular tal como depresion,
WO2006135839A3 (en) Piperazine-piperidine antagonists and agonists of the 5-ht1a receptor
WO2006033795A3 (en) Substituted pyrazolo [1, 5-a] pyrimidines for inhibiting abnormal cell growth
DE60318405D1 (de) Verfahren zur herstellung von diaminodiphenylmethan und seinen höheren homologen
DK1678182T3 (da) Fremgangsmåde til fremstilling af substituerede 5-amino-pyrazolo[4,3-E]-1,2,4-triazolo-[1,5-C]pyrimidiner
ATA11742004A (de) Neue derivate des 4a,5,9,10,11,12-hexahydro- benzofuro(3a,3,2)(2) benzazepin, verfahren zu deren herstellung sowie deren verwendung zur herstellung von arzneimitteln
CY1110757T1 (el) Πυραζολο-[1,5-α]πυριμιδινες, διεργασιες, χρησεις και συνθeσεις
AU4698199A (en) Pyrazolo(1,5-a)triazine corticotropin releasing factor antagonists
WO2004048318A8 (en) Improved process for the preparation of 1,3-substituted indenes
DE60332874D1 (de) Pyren-gebundene pyrrolo(2,1-c)(1,4)benzodiazepin-derivate zur verwendung als antikrebsmittel

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A, 6A E 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2144 DE 07/02/2012.